Session 19: Debate: Are All CDK4/6 Inhibitors Created Equal? - DISCUSSION

Moderator(s)

• 

  Erika P. Hamilton, MD

  Sarah Cannon Research Institute (SCRI)
  Nashville, Tennessee

Panelist(s)

• 

  David Cescon, MD, PhD

  Princess Margaret Cancer Centre
  Toronto, Ontario
• 

  Dejan Juric, MD

  Mass General Cancer Center, Harvard Medical School
  Boston, Massachusetts